Considering that BIM is a known target of CRLs [41], it is possible that simultaneous inhibition of the NEDD8 conjugation pathway and the MEK/ERK signaling leading to stabilization of BIM and increased BIM pro-apoptotic activity, respectively, will result in synergistic ALL cell death. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.